MedTrace Logo

Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression

NCT00333931 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2006-06-06

No results posted yet for this study

Summary

The purpose of this study is to identify changes in brain functioning which are related to reduced frequency and/or intensity of impulsive aggressive actions after treatment of PTSD-related impulsive aggression with either phenytoin or cognitive behavioral therapy.

Conditions

Interventions

DRUG

Phenytoin

BEHAVIORAL

Cognitive Behavioral Therapy

Sponsors & Collaborators

  • Dr. Thomas A. Kent

    collaborator UNKNOWN

  • Dr. Stacey Holmes

    collaborator UNKNOWN

  • Dr. Su Bailey

    collaborator UNKNOWN

  • Dr. Mark Kunik

    collaborator UNKNOWN

  • Dr. Melinda Stanley

    collaborator UNKNOWN

  • Michael E. DeBakey VA Medical Center

    lead FED

Principal Investigators

  • Thomas A Kent, MD · Veterans Affairs Medical Center-Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333931 on ClinicalTrials.gov